cefepime Injection 1 g
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20700
This CTD dossier owner and manufacturer, established in 1988, boasts over three decades of experience serving a region. They offer a comprehensive range of products, from unbranded generics to licensed prescription drugs, catering to diverse healthcare needs. Their Consumer Health Division extends this reach with over-the-counter medications, supplements, and preventive products. The company prioritizes quality and operates with a commitment to improving the well-being of its customers. They manufacture a broad spectrum of dosage forms, including solids, liquids, and injectables, adhering to strict quality standards reflected in their EU and USA GMP certifications.
Cefepime is an antibiotic used to treat a wide range of bacterial infections, including intraabdominal, kidney, skin, urinary tract infections as well as pneumonia. Suppliers of cefepime market it in the form of powders for injectable solutions.
The developer and earliest manufacturer of cefepime is Bristol-Myers Squibb who first introduced it into the market in 1994 under the trade name Maxipime. Currently, major manufacturers of cefepime medications include companies such as Berr Chem, Hangzhou Viwa, Nectar Lifesciences, ACS Dobfar, and Qilu Pharmaceutical.
Cefepime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefepime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 10g of cefepime powder falls into an approximate range of 120 EUR to 160 EUR.